Efficacy and Safety of Rivastigmine Capsules in Patients With Probable Vascular Dementia

Clinical trial NCT00099216 · COMPLETED

Trial details

NCT number: NCT00099216
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Vascular Dementia

Start date: 2001-08-01
Primary completion: 2005-11-01
Enrollment: 708

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.